. 2010 Dec 23;3(1):17–42. doi: 10.3390/cancers3010017

Table 3.

In vitro evaluations of polymeric-paclitaxel micelles and Taxol in various cancer cell lines.

Cancer	Drug	Genexol-PM	Taxol	NK-105	Taxol	NK-105	Taxol
	Drug	IC₇₀ (μg/mL)		IC₅₀ (μM)		IC₅₀ (μM)
	Tumor cell line	(96 h drug exposure)		(48 h drug exposure)		(72 h drug exposure)
Eesophageal	TE-1			>1.0	>1.0	0.01	0.02
	TE-8			0.02	0.02	0.01	0.01
Lung	PC-14			0.01	0.01	0.01	0.01
	PC-14/TXT			0.15	0.09	0.08	0.06
	H460					0.03	0.01
Breast	MCF-7	0.002	0.002	>1.0	>1.0	0.01	0.01
Stomach	MKN-28			0.03	0.03	0.01	0.21
	MKN-45			0.02	0.07	0.01	0.02
Colon	DLD-1			0.95	0.26	0.29	0.20
	HT-29			0.01	0.01	0.01	0.01
	HCT116					0.03	0.01
Ovarian	MCAS			0.01	0.01	0.01	0.01
	OVCAR-3	0.002	0.004	>1.0	>1.0	>1.0	>1.0
Pancreatic	AsPC-1					0.02	0.02
	PAN-9					0.03	0.02
	PAN-3					0.01	0.004
Ref.		[25]		[24]